Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William L Read

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Case Reports in Oncology|February 7, 2024
Rare Delayed Ifosfamide Encephalopathy: A Case Report of Chemotherapeutic NeurotoxicityAmbika Menon, Chidiebele A Enunwa, William L Read, et al.
Plos One|September 5, 2019
The use of a predictive statistical model to make a virtual control arm for a clinical trialJeffrey M Switchenko, Arielle L Heeke, Tony C Pan, et al.
JAAD Case Reports|April 7, 2016
Squamous cell carcinomas of the skin responsive to erlotinib: 5 casesWilliam L Read, Kevin T Brumund, Robert A Weisman, et al.
Lung Cancer (Amsterdam, Netherlands)|July 13, 2004
The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER databaseWilliam L Read, Nathan C Page, Ryan M Tierney, et al.
Journal of Neuro-Oncology|August 10, 2016
Phase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastomaD Jay McCracken, Emma C Celano, Alfredo D Voloschin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Differential prognostic impact of comorbidityWilliam L Read, Ryan M Tierney, Nathan C Page, et al.
Investigational New Drugs|May 13, 2009
A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumorsAnne M Traynor, Michael S Gordon, Dona Alberti, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A phase II study of irinotecan and carboplatin in advanced non-small cell lung cancer with pharmacogenomic analysis: final reportGiancarlo A Pillot, William L Read, Kristin L Hennenfent, et al.
Acta Cytologica|August 19, 2010
Pulmonary langerhans cell histiocytosis diagnosed in a cervical lymph node: a case reportRichard T Scuderi, Samir S Makani, Colleen L Channick, et al.
Cancer Chemotherapy and Pharmacology|February 13, 2013
Phase I study to assess the pharmacokinetics and the effect on cardiac repolarization of amrubicin and amrubicinol in patients with advanced solid tumorsNianhang Chen, Sant P Chawla, Elena Gabriela Chiorean, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Case Reports in Oncology|February 7, 2024
Rare Delayed Ifosfamide Encephalopathy: A Case Report of Chemotherapeutic NeurotoxicityAmbika Menon, Chidiebele A Enunwa, William L Read, et al.
Plos One|September 5, 2019
The use of a predictive statistical model to make a virtual control arm for a clinical trialJeffrey M Switchenko, Arielle L Heeke, Tony C Pan, et al.
JAAD Case Reports|April 7, 2016
Squamous cell carcinomas of the skin responsive to erlotinib: 5 casesWilliam L Read, Kevin T Brumund, Robert A Weisman, et al.
Lung Cancer (Amsterdam, Netherlands)|July 13, 2004
The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER databaseWilliam L Read, Nathan C Page, Ryan M Tierney, et al.
Journal of Neuro-Oncology|August 10, 2016
Phase I trial of dose-escalating metronomic temozolomide plus bevacizumab and bortezomib for patients with recurrent glioblastomaD Jay McCracken, Emma C Celano, Alfredo D Voloschin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2004
Differential prognostic impact of comorbidityWilliam L Read, Ryan M Tierney, Nathan C Page, et al.
Investigational New Drugs|May 13, 2009
A dose escalation, safety, and tolerability study of MN-029 in patients with advanced solid tumorsAnne M Traynor, Michael S Gordon, Dona Alberti, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A phase II study of irinotecan and carboplatin in advanced non-small cell lung cancer with pharmacogenomic analysis: final reportGiancarlo A Pillot, William L Read, Kristin L Hennenfent, et al.
Acta Cytologica|August 19, 2010
Pulmonary langerhans cell histiocytosis diagnosed in a cervical lymph node: a case reportRichard T Scuderi, Samir S Makani, Colleen L Channick, et al.
Cancer Chemotherapy and Pharmacology|February 13, 2013
Phase I study to assess the pharmacokinetics and the effect on cardiac repolarization of amrubicin and amrubicinol in patients with advanced solid tumorsNianhang Chen, Sant P Chawla, Elena Gabriela Chiorean, et al.
Pageof 3